V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20212630 | 20128883 | null | null | Palliative (P) | 2021-02-08 | 2021-02-09 | ECX | 02 | N | ECX | 101711050 |
| 20212631 | 20128884 | 1.87 | 75.6 | null | 2019-08-27 | 2019-09-10 | ECX | 02 | null | ECX | 101064080 |
| 20212633 | 20128885 | 1.62 | 42 | Palliative (P) | 2017-12-20 | 2018-01-10 | null | 02 | N | CISPLATIN + FLUOROURACIL | 101366201 |
| 20212635 | 20128887 | 1.63 | 68.6 | Palliative (P) | 2019-09-03 | 2019-09-09 | Panitumumab | 02 | null | PANITUMUMAB | 101467907 |
| 20212638 | 20128888 | 1.78 | null | Adjuvant (A) | 2020-03-14 | 2020-04-04 | Carboplatin + Etoposide IV 3 day | 02 | N | PANITUMUMAB | 101531523 |
| 20212640 | 20128889 | 1.63 | 88 | null | 2017-03-02 | 2017-03-02 | null | 02 | null | CARBOPLATIN + ETOPOSIDE | 101570229 |
| 20212643 | 20128890 | 1.66 | null | Adjuvant (A) | null | 2019-10-14 | null | 02 | N | CISPLATIN + FLUOROURACIL | 100372930 |
| 20212644 | 20128891 | 1.64 | 81 | Palliative (P) | 2019-08-03 | 2019-08-09 | null | 02 | N | ECX | 100189452 |
| 20212646 | 20128892 | 1.67 | null | Palliative (P) | 2018-05-26 | 2018-06-12 | Panitumumab | 02 | N | PANITUMUMAB | 100359117 |
| 20212648 | 20128894 | 1.7 | 79.65 | Palliative (P) | null | 2021-08-20 | ECX | N | N | ECX | 100266495 |
| 20212649 | 20128895 | 1.6 | 105 | Palliative (P) | 2021-02-28 | 2021-02-28 | NPC Cisplatin/5 flourouracil | N | N | CISPLATIN + FLUOROURACIL | 101126828 |
| 20212650 | 20128896 | 1.59 | 69.3 | Palliative (P) | 2017-05-25 | 2017-06-15 | Cisplatin +Fluorouracil (3 wk) | 02 | null | CISPLATIN + FLUOROURACIL | 100450023 |
| 20212651 | 20128897 | 1.55 | 71 | Curative (C) | 2015-08-16 | 2020-08-16 | null | N | N | PANITUMUMAB | 101281902 |
| 20212652 | 20128898 | 1.69 | 68.6 | Palliative (P) | 2018-12-10 | 2018-12-10 | Panitumumab | null | N | CARBOPLATIN + ETOPOSIDE | 100910148 |
| 20212654 | 20128899 | 1.79 | null | Palliative (P) | 2018-08-12 | 2018-08-20 | CISPLATIN + FLUOROURACIL | 01 | N | CISPLATIN + FLUOROURACIL | 101830278 |
| 20212655 | 20128900 | 1.64 | 80 | null | 2016-10-13 | 2016-11-04 | CISPLATIN + FLUOROURACIL + RT | 02 | null | CISPLATIN + FLUOROURACIL | 101219392 |
| 20212656 | 20128901 | 1.75 | 75.6 | Palliative (P) | 2017-05-10 | 2017-05-10 | NIVOLUMAB | 02 | N | NIVOLUMAB | 101853698 |
| 20212661 | 20128904 | 1.81 | null | null | null | 2018-04-04 | null | 02 | null | PANITUMUMAB | 101790355 |
| 20212662 | 20128905 | 1.71 | null | Palliative (P) | 2019-08-10 | 2019-08-10 | Carboplatin + Etoposide iv&po | 02 | N | CARBOPLATIN + ETOPOSIDE | 100697243 |
| 20212663 | 20128906 | 1.75 | 84.3 | Curative (C) | 2017-11-09 | 2017-11-09 | null | 2 | N | PANITUMUMAB | 100762404 |
| 20212667 | 20128907 | 1.59 | 62 | Palliative (P) | 2018-04-29 | 2018-10-18 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 100268146 |
| 20212674 | 20128908 | null | null | Palliative (P) | 2017-02-18 | 2017-04-28 | null | 02 | N | ECX | 101528707 |
| 20212676 | 20128910 | 1.64 | null | Neo-adjuvant (N) | 2016-07-24 | 2016-07-24 | null | 02 | N | PANITUMUMAB | 100851515 |
| 20212677 | 20128911 | 1.75 | 75.6 | Palliative (P) | 2018-03-16 | 2018-12-07 | Carboplatin + Etoposide iv&po | N | N | CARBOPLATIN + ETOPOSIDE | 101431171 |
| 20212680 | 20128913 | 1.7 | 74.88 | Adjuvant (A) | 2017-08-17 | 2017-08-17 | Carboplatin + Etoposide iv&po | 02 | null | ECX | 100530215 |
| 20212684 | 20128915 | 1.72 | 111.3 | Palliative (P) | 2017-11-23 | 2017-11-23 | Cisplatin + Modified de Gramont | 2 | N | CISPLATIN + FLUOROURACIL | 101322392 |
| 20212687 | 20128916 | 1.8 | 74.8 | Neo-adjuvant (N) | 2019-11-19 | 2019-11-26 | Cisplatin +Fluorouracil (3 wk) | 02 | N | CISPLATIN + FLUOROURACIL | 101372772 |
| 20212689 | 20128917 | 1.64 | null | Palliative (P) | 2020-01-11 | 2020-01-24 | CISPLATIN + FLUOROURACIL | N | N | CISPLATIN + FLUOROURACIL | 101154575 |
| 20212690 | 20128918 | 1.71 | 75.6 | Palliative (P) | 2019-04-09 | 2019-04-13 | null | 02 | N | ECX | 100548158 |
| 20212691 | 20128919 | 1.65 | 73.1 | Curative (C) | 2016-08-02 | 2016-08-14 | null | 02 | N | NIVOLUMAB | 100200212 |
| 20212695 | 20128920 | 1.66 | 65.3 | Palliative (P) | 2015-12-27 | 2016-05-15 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 101842993 |
| 20212696 | 20128921 | 1.65 | 79 | Palliative (P) | 2017-11-11 | 2019-07-06 | null | 02 | N | ECX | 100887405 |
| 20212700 | 20128922 | 1.77 | null | Palliative (P) | 2018-11-09 | 2018-11-10 | null | 02 | N | CARBOPLATIN + ETOPOSIDE | 100537029 |
| 20212703 | 20128923 | 1.59 | 42.9 | Palliative (P) | 2020-04-10 | 2020-05-28 | null | 02 | null | CISPLATIN + FLUOROURACIL | 100117625 |
| 20212704 | 20128924 | 1.67 | 52.4 | Adjuvant (A) | 2019-04-15 | 2019-04-15 | NIVOLUMAB | 02 | N | NIVOLUMAB | 101818793 |
| 20212705 | 20128925 | 0 | 68 | null | 2019-06-11 | 2019-06-15 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 100202387 |
| 20212706 | 20128926 | 1.66 | 61.4 | Palliative (P) | 2019-05-06 | 2019-05-06 | null | 02 | N | PANITUMUMAB | 100969766 |
| 20212707 | 20128927 | 1.62 | 63 | Palliative (P) | 2017-08-08 | 2017-08-09 | null | 2 | N | ECX | 100141966 |
| 20212708 | 20128928 | 1.7 | 83.9 | Palliative (P) | null | 2018-02-16 | null | 02 | null | CISPLATIN + FLUOROURACIL | 101596928 |
| 20212718 | 20128930 | 1.66 | 57.25 | Palliative (P) | 2021-01-18 | 2021-02-22 | null | 02 | N | CARBOPLATIN + ETOPOSIDE | 100978432 |
| 20212719 | 20128931 | null | 62.3 | Palliative (P) | 2017-07-01 | 2017-07-15 | Panitumumab | 02 | N | PANITUMUMAB | 101465364 |
| 20212721 | 20128932 | 1.61 | 91 | null | 2019-01-16 | 2019-01-16 | Panitumumab | 02 | N | PANITUMUMAB | 101444951 |
| 20212723 | 20128934 | null | null | Palliative (P) | 2017-06-03 | 2017-06-12 | null | 02 | N | PANITUMUMAB | 101208151 |
| 20212724 | 20128935 | 1.56 | 66 | Curative (C) | 2020-03-06 | 2020-03-17 | null | 02 | null | NIVOLUMAB | 101311161 |
| 20212726 | 20128937 | 1.71 | null | Palliative (P) | 2018-01-01 | 2018-01-12 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 101500952 |
| 20212728 | 20128938 | 1.72 | 74.9 | Palliative (P) | 2021-04-25 | 2021-05-09 | null | N | N | ECX | 100299300 |
| 20212730 | 20128939 | 1.76 | 75.2 | Palliative (P) | 2017-05-20 | 2017-05-20 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 101624818 |
| 20212733 | 20128941 | 1.81 | 72.1 | Disease modification (D) | 2019-08-26 | 2019-08-26 | CISPLATIN + FLUOROURACIL + RT | 02 | N | CISPLATIN + FLUOROURACIL | 100647613 |
| 20212734 | 20128942 | 1.61 | 82.3 | null | 2019-08-08 | 2019-08-08 | null | N | null | NIVOLUMAB | 100280656 |
| 20212737 | 20128943 | 1.77 | null | Palliative (P) | 2016-04-18 | 2016-04-25 | CARBOPLATIN + ETOPOSIDE | null | N | CARBOPLATIN + ETOPOSIDE | 100832078 |